|
Nephros and Bellco S.r.l. Announce License Agreement for Mid-Dilution Dialysis ... - Sacramento Bee |
Sacramento Bee
The Nephros hemodiafiltration (HDF) system is designed to improve the quality of life for the End-Stage Renal Disease (ESRD) patient while addressing the critical financial and clinical needs of the care provider. ESRD is a disease state characterized ...
Nephros and Bellco S.r.l. Announce License Agreement for Mid-Dilution Dialysis
|
|
Nephros and Bellco S.r.l. Announce License Agreement for Mid-Dilution Dialysis ... - PR Newswire (press release) |
PR Newswire (press release)
That agreement, which is effective July 1, 2011, grants Bellco exclusive rights to market Nephros' patented mid-dilution dialysis filters (MD 190, MD 220) in Canada and certain European countries. "Bellco is currently Nephros' distribution partner in
|
|
Vitae Reports Positive Clinical Data in Chronic Kidney Disease Program at the ... - SunHerald.com |
SunHerald.com
The RAAS pathway is considered to have a central role in the progression of chronic kidney disease, particularly in diabetes, and diabetic nephropathy is the leading cause of end-stage renal disease (ESRD). The clinical findings were presented in a ...
Vitae Reports Positive Clinical Data in Chronic Kidney Disease Program at the
|
|
Vitae Reports Positive Clinical Data in Chronic Kidney Disease Program at the ... - Gamut News (press release) |
Gamut News (press release)
The RAAS pathway is considered to have a central role in the progression of chronic kidney disease, particularly in diabetes, and diabetic nephropathy is the leading cause of end-stage renal disease (ESRD). The clinical findings were presented in a
|
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
